Pfizer tells Centre its vaccine suitable for 12 years and above

Pfizer tells Centre its vaccine suitable for 12 years and above

Pfizer tells Centre its vaccine suitable for 12 years and above

Provincial health officer Dr. Bonnie Henry and Health Minister Adrian Dix announced Thursday that now recommending an eight-week gap between shots, down from the 16 weeks previously announced. Moderna notes that it will gather data until 12 months after each participant's second dose of the vaccine to continue to assess the vaccine's safety in the long term. Seniors, Indigenous people, and people who identify as Clinically Extremely Vulnerable (CEV) will be prioritized, with invitations already going out to those who are eligible.

He was the second-ever person to receive the vaccine, after 91-year-old Irish woman Margaret Keenan; both received the Pfizer-BioNTech jab in a Coventry hospital at the tail-end of 2020. Among all those ages 12 and older who are now eligible, roughly 62 per cent have received a first dose, she added.

"We are making great strides and we want to keep this momentum going", she said. Shakespeare said at the time, according to CBS News.

Second doses will be prioritized and given similar to the first doses.

There is a data discrepancy between Island Health and the province, based on the timing of COVID-19 results.

She added that they have enough supply for British Columbians to receive a second dose of AstraZeneca and she's not anxious about expiration dates, meaning people will have time to make a proper decision.

"Bill was so grateful for being offered the opportunity to become one of the first people in the world to be given the vaccine. And I would encourage people to take the Pfizer, if it is on offer", she said. "We know that it is safe and works just as well if you have one or the other of the mRNA vaccines".

In the study, a vaccine efficacy rate of 93 percent was observed more than 14 days after the first dose.

While India has administered over 20 crore doses so far since the launch of its vaccination drive in mid-January, it is still a long way to reach the vaccination for the entire population, more so in the backdrop of many states having flagged shortage of vaccines and the gap between supply and requirement widening amid the deadly second wave.

Related news

[an error occurred while processing the directive]